Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era Eric Van CutsemSabine Tejpar Editorial 13 November 2008 Pages: 223 - 225
Functional inactivation of CD4+CD25high regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity Riki OkitaYoshiyuki YamaguchiKazuo Matsuura Original Research 11 November 2008 Pages: 227 - 234
Mechanisms of resistance to EGFR tyrosine kinase inhibitors: implications for patient selection and drug combination strategies Alexandra EyzaguirreElizabeth BuckMark R. Miglarese Review Open access 24 October 2008 Pages: 235 - 243
Management of skin toxicity of epidermal growth factor receptor inhibitors Siegfried Segaert Day-to-Day Practice 08 October 2008 Pages: 245 - 251
Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report F. VitielloV. RicciF. Ciardiello Day-to-Day Practice 30 October 2008 Pages: 253 - 258
Successful treatment of brain metastases from renal cell cancer using radiotherapy in combination with sorafenib Ulrika StiernerZahra Taheri-Kadkhoda Day-to-Day Practice 08 October 2008 Pages: 259 - 264
Plasma cell leukemia: advantages of treatment with bortezomib N. FraimoutB. KadouchN. Mounier Day-to-Day Practice 20 November 2008 Pages: 265 - 267
